Wisconsin Corp For Biomedical Research

Wisconsin Corp For Biomedical Research, operating as the Wisconsin Corporation For Biomedical Research Division, is a non-profit organization registered to receive federal contract and grant awards. The entity specializes in biomedical research and provides support for clinical trials and specimen collection and analysis. Registered in SAM.gov since November 16, 2016, with an active registration until April 4, 2025, this tax-exempt corporate entity primarily engages in research activities that contribute to advancements in medical science and healthcare.

As a subcontractor, Wisconsin Corp For Biomedical Research has been involved in federal contract work related to chronic obstructive pulmonary disease (COPD) research. Under a subcontract with Georgia TECH Research Corp as the prime contractor, the organization proposed to collect sputum and blood specimens from 20 research participants with established COPD diagnoses. The study aimed to enroll ex-smokers between 40 and 80 years of age, conducting pulmonary function tests and collecting demographic, anthropometric, functional, and imaging data. The research involved detailed procedures for specimen collection, handling, and analysis, with a focus on maintaining a full chain of custody for all samples throughout their lifecycle. This contract demonstrates the organization's capability to conduct specialized clinical research and manage complex biological specimen collection and analysis protocols.

In the realm of federal grant awards, Wisconsin Corp For Biomedical Research has participated as a subrecipient in the PREVENTABLE (Pragmatic Evaluation of Events and Benefits of Lipid-Lowering in Older Adults) trial. Working under Duke University as the prime grantee, the organization's role involved providing coordination and logistical support for the collection, processing, and storage of baseline samples from 17,000 participants randomized in the PREVENTABLE trial. This large-scale biorepository project showcases the entity's capacity to manage substantial biospecimen collections and contribute to significant clinical research initiatives. The involvement in this grant-funded work highlights Wisconsin Corp For Biomedical Research's expertise in handling large-scale clinical trials and managing complex biospecimen logistics in support of critical medical research efforts.